By

Djordje
A phase II study of veliparib and local irradiation followed by maintenance veliparib and temozolomide in children with newly diagnosed high grade glioma (HGG).
Read More
A phase II study of reduced therapy for newly diagnosed average-risk WNT-Driven medulloblastoma.
Read More
A randomized phase trial looking at the use of inotuzumab in newly diagnosed high risk B-ALL.
Read More
A trial testing the effects of pembrolizumab with or without chemotherapy treatment for patients 70 years of age and older with advanced non small cell lung cancer.
Read More
A prospective study collecting tissue samples to help guide treatment decisions in invasive breast cancer. No randomization required.
Read More
A prospective study collecting tissue samples to help guide treatment decisions in pre-invasive breast cancer.  No randomization required.
Read More
A weight-loss study after breast cancer.  No randomization required.
Read More
A randomized phase III trial evaluating pembrolizumab in the after chemotherapy and surgery in advanced breast cancer
Read More
A randomized, phase III trial for patients with locally advanced, lymph node positive breast cancer who undergo chemotherapy neoadjuvantly (up front) and are randomized to axillary dissection versus no axillary dissection at the time of surgery.
Read More
Women with node positive breast cancer normally will receive endocrine therapy and some may receive chemotherapy to help prevent the cancer from coming back.
Read More
1 2 3

Recent Articles

Tampa Style Magazine Names Dr. Paryani To Top Doctors 2022 List
May 3, 2022
Dr. Paryani was recently interviewed about our prostate cancer program
May 3, 2022
Dr. Paryani was recently interviewed by BrainLab discussing radiosurgery for cancer patients
February 17, 2022

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Services